The board of directors of China Resources Pharmaceutical Group Limited announced that, with effect from 7 September 2021: Mr. Li Xiangming has ceased to be an executive director, a vice chairman and a member of the executive committee of the Company owing to other work arrangements; Mr. Yu Zhongliang has ceased to be a non-executive director of the Company owing to other work arrangements; and Mdm. Guo Wei has ceased to be a non-executive director, a member of the audit committee and a member of the remuneration committee of the Company owing to other work arrangements. Mr. Tao Ran has been appointed an executive director and a member of the executive committee of the Company; Mr. Lin Guolong has been appointed a non-executive director, a member of the audit committee and a member of the remuneration committee of the Company; and Mr. Tan Ying has been appointed a non-executive director of the Company. Mr. Tao Ran was appointed as vice president of the Company in June 2021. He is concurrently a director of China Resources Jiangzhong Pharmaceutical Group Co. Ltd. Mr. Lin Guolong has been a designated external director of the business unit of China Resources (Holdings) Company Limited since August 2021. Mr. Tan Ying, has been vice president of CR Sanjiu since April 2013. Mr. Tan had been a director of the technology centre, chief technology officer and chief R&D technology officer at CR Sanjiu from January 2006 to July 2012.